Anyone administering the canine ear infection drugs Claro or Osurnia should take care to avoid contact with eyes, the U.S. Food and Drug Administration is advising.<\/p>\n
The agency on Dec. 6 reported a number of adverse events after the medications accidentally got into the eyes of dogs or people.<\/p>\n
The gel medication Osurnia (florfenicol\/terbinafine\/betamethasone acetate) reportedly caused corneal ulcers in 10 dogs and two veterinary technicians as of Oct. 17, the FDA stated. Claro (florfenicol\/terbinafine\/mometasone furoate), a clear liquid, was linked to 10 reports of corneal ulcers in dogs.<\/p>\n
\u201cIn some reports, the eye injuries occurred after the medication was applied to the ear(s) and the dog shook its head,\u201d the FDA noted. \u201cOther reports simply state that medication splashed into the eyes of the person.\u201d<\/p>\n
An undisclosed number of veterinary professionals and pet owners \u201cwho were near the dog during or after application of Osurnia or Claro\u201d complained of eye irritation or burning, the FDA added.<\/p>\n
Osurnia\u2019s manufacturer, Elanco Animal Health, stated that the company \u201cis committed to the safety of dogs using our products and the people administering them.\u201d<\/p>\n
\u201cIn this instance, the cases were detected by Elanco\u2019s own pharmacovigilance monitoring and immediately reported to the FDA,\u201d Elanco stated. \u201cWe will continue our aggressive monitoring program and are currently assessing what further steps may be needed to assist clinicians in best practice management.<\/p>\n
\u201cOsurnia\u2019s warning contained within the U.S. label states to avoid eye contact, and in the event of accidental skin contact, instructs that the area should be washed thoroughly with water.\u201d<\/p>\n
Bayer Animal Health, which makes Claro, noted that the medication has been in widespread use since its introduction in 2015.<\/p>\n
\u201cBayer has sold over 1.5 million doses of Claro to veterinary clinics across the U.S., treating more than 750,000 dogs,\u201d the company reported.<\/p>\n
\u201cTo date, zero reports of corneal ulcers have been reported in people associated with the use of Claro.\u201d<\/p>\n
Like the FDA, Bayer advised that care be taken to avoid eye injuries.<\/p>\n
\u201cIf accidental exposure to the eyes of people or dogs occurs, seek medical care,\u201d Bayer added.<\/p>\n
The company pointed out that Claro and Osurnia differ in one active ingredient, their inactive ingredients and the labeled dosing regimen.<\/p>\n","protected":false},"excerpt":{"rendered":"
Formulated for canine ears, the medications can irritate the eyes of people and dogs.<\/p>\n","protected":false},"author":7,"featured_media":1728,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"iawp_total_views":0,"footnotes":""},"categories":[90],"tags":[],"class_list":["post-1727","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-online","column-news","clinical_topics-news"],"acf":{"hide_sidebar":false,"hide_sidebar_ad":false,"hide_all_ads":false},"yoast_head":"\n